Katsuto Shinohara, MD

Title(s)Professor, Urology
SchoolSchool of Medicine
Address550 16th Street, #6209
San Francisco CA 94158
Phone415-353-7171
ORCID ORCID Icon0000-0002-0409-0264 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Yokohama City Univ. School of Medicine Japan1979
    Baylor College of MedicineFellowship

    Collapse Overview 
    Collapse Overview
    Dr. Katsuto Shinohara specializes in urologic cancers, in particular prostate cancer. He has special interests in innovative biopsy techniques and image-guided minimally invasive treatments for prostate cancer, as well as in applying ultrasound techniques in the diagnosis, management and treatment of all urologic cancers.

    Shinohara earned his medical degree from Yokohama City University School of Medicine in Yokohama, Japan. He completed a residency in general surgery at Mitsui Memorial Hospital in Tokyo, Japan, and a residency in urology at Kitasato University Hospital in Sagamihara, Japan. He then completed a fellowship in urologic oncology at Baylor College of Medicine in Houston, Texas.

    Shinohara is a member of numerous professional societies, including the Japanese Urological Association, Japan Society of Ultrasonics in Medicine, American Institute of Ultrasound in Medicine, American Urological Association and Engineering & Urology Society. He has lectured widely on urologic cancer, and his work has been published in numerous medical and scientific journals.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Targeted Biopsy Is Sufficient for Men on Active Surveillance for Early-Stage Prostate Cancer. J Urol. 2024 Oct 09; 101097JU0000000000004265. Fakunle MO, Cowan JE, Washington SL, Shinohara K, Nguyen HG, Carroll PR. PMID: 39383376.
      View in: PubMed   Mentions:    Fields:    
    2. Determining Long-term Prostate Cancer Outcomes for Active Surveillance Patients Without Early Disease Progression: Implications for Slowing or Stopping Surveillance. Eur Urol Oncol. 2024 Sep 27. Shee K, Nie J, Cowan JE, Wang L, Washington SL, Shinohara K, Nguyen HG, Cooperberg MR, Carroll PR. PMID: 39341710.
      View in: PubMed   Mentions:    Fields:    
    3. The Impact of Delayed Radical Prostatectomy on Recurrence Outcomes After Initial Active Surveillance: Results from a Large Institutional Cohort. Eur Urol Oncol. 2024 Aug; 7(4):838-843. Shee K, Cowan JE, Washington SL, Shinohara K, Nguyen HG, Cooperberg MR, Carroll PR. PMID: 38057193.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Effect of a Home-based Walking Intervention on Cardiopulmonary Fitness and Quality of Life Among Men with Prostate Cancer on Active Surveillance: The Active Surveillance Exercise Randomized Controlled Trial. Eur Urol Oncol. 2024 Jun; 7(3):519-526. Van Blarigan EL, Kenfield SA, Olshen A, Panchal N, Encabo K, Tenggara I, Graff RE, Bang AS, Shinohara K, Cooperberg MR, Carroll PR, Jones LW, Winters-Stone K, Luke A, Chan JM. PMID: 37907387.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    5. Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement. Eur Urol. 2023 12; 84(6):547-560. Deivasigamani S, Kotamarti S, Rastinehad AR, Salas RS, de la Rosette JJMCH, Lepor H, Pinto P, Ahmed HU, Gill I, Klotz L, Taneja SS, Emberton M, Lawrentschuk N, Wysock J, Feller JF, Crouzet S, Kumar M P, Seguier D, Adams ES, Michael Z, Abreu A, Jack Tay K, Ward JF, Shinohara K, Katz AE, Villers A, Chin JL, Stricker PD, Baco E, Macek P, Ahmad AE, Chiu PKF, Crawford ED, Rogers CG, Futterer JJ, Rais-Bahrami S, Robertson CN, Hadaschik B, Marra G, Valerio M, Chong KT, Kasivisvanathan V, Tan WP, Lomas D, Walz J, Guimaraes GC, Mertziotis NI, Becher E, Finelli A, Kasraeian A, Lebastchi AH, Vora A, Rosen MA, Bakir B, Arcot R, Yee S, Netsch C, Meng X, de Reijke TM, Tan YG, Regusci S, Benjamin TGR, Olivares R, Noureldin M, Bianco FJ, Sivaraman A, Kim FJ, Given RW, Dason S, Sheetz TJ, Shoji S, Schulman A, Royce P, Shah TT, Scionti S, Salomon G, Laguna P, Tourinho-Barbosa R, Aminsharifi A, Cathelineau X, Gontero P, Stabile A, Grummet J, Ledbetter L, Graton M, Stephen Jones J, Polascik TJ, Focal Therapy Society. PMID: 37419773.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    6. Stability of Prognostic Estimation Using the CAPRA Score Incorporating Imaging-based vs Physical Exam-based Staging. J Urol. 2023 08; 210(2):281-289. Chang K, Greenberg SA, Cowan JE, Parker R, Shee K, Washington SL, Nguyen HG, Shinohara K, Carroll PR, Cooperberg MR. PMID: 37099018.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    7. Limited Relevance of the Very Low Risk Prostate Cancer Classification in the Modern Era: Results from a Large Institutional Active Surveillance Cohort. Eur Urol. 2023 07; 84(1):9-12. Shee K, Cowan JE, Balakrishnan A, Escobar D, Chang K, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 36870794.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Improving multiparametric MR-transrectal ultrasound guided fusion prostate biopsies with hyperpolarized 13 C pyruvate metabolic imaging: A technical development study. Magn Reson Med. 2022 Dec; 88(6):2609-2620. Chen HY, Bok RA, Cooperberg MR, Nguyen HG, Shinohara K, Westphalen AC, Wang ZJ, Ohliger MA, Gebrezgiabhier D, Carvajal L, Gordon JW, Larson PEZ, Aggarwal R, Kurhanewicz J, Vigneron DB. PMID: 35975978; PMCID: PMC9794017.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    9. Medium Term Outcomes of Focal Cryoablation for Intermediate and High Risk Prostate Cancer: MRI and PSA are Not Predictive of Residual or Recurrent Disease. Urol Oncol. 2022 10; 40(10):451.e15-451.e20. Baskin A, Charondo LB, Balakrishnan A, Cowan JE, Cooperberg MR, Carroll PR, Nguyen H, Shinohara K. PMID: 35851186.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    10. Patient engagement in a mobile health intervention to improve preparedness for prostate biopsy. Urol Oncol. 2022 09; 40(9):407.e1-407.e7. Balakrishnan AS, Nguyen HG, Shinohara K, Carroll PR, Odisho AY. PMID: 35840464.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. US lesion visibility predicts clinically significant upgrade of prostate cancer by systematic biopsy. Abdom Radiol (NY). 2022 03; 47(3):1133-1141. Velarde N, Westphalen AC, Nguyen HG, Neuhaus J, Shinohara K, Simko JP, Larson PE, Magudia K. PMID: 34997299; PMCID: PMC8863714.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. The Natural History of Untreated Biopsy Grade Group Progression and Delayed Definitive Treatment for Men on Active Surveillance for Early-Stage Prostate Cancer. J Urol. 2022 05; 207(5):1001-1009. Chappidi MR, Bell A, Cowan JE, Greenberg SA, Lonergan PE, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 34981949.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Salvage High-Dose-Rate Brachytherapy for Recurrent Prostate Cancer After Definitive Radiation. Pract Radiat Oncol. 2021 Nov-Dec; 11(6):515-526. Wu SY, Wong AC, Shinohara K, Roach M, Cunha JAM, Valdes G, Hsu IC. PMID: 34077809.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    14. Diagnostic Accuracy and Prognostic Value of Serial Prostate Multiparametric Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer. Eur Urol Oncol. 2022 10; 5(5):537-543. Chu CE, Cowan JE, Lonergan PE, Washington SL, Fasulo V, de la Calle CM, Shinohara K, Westphalen AC, Carroll PR. PMID: 33483265.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    15. Long-Term Results of NRG Oncology/RTOG 0321: A Phase II Trial of Combined High Dose Rate Brachytherapy and External Beam Radiation Therapy for Adenocarcinoma of the Prostate. Int J Radiat Oncol Biol Phys. 2021 Jul 01; 110(3):700-707. Hsu IC, Rodgers JP, Shinohara K, Purdy J, Michalski J, Roach M, Vigneault E, Ivker RA, Pryzant RM, Kuettel M, Taussky D, Gustafson GS, Raben A, Sandler HM. PMID: 33186617; PMCID: PMC8107184.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    16. Characteristics of Cancer Progression on Serial Biopsy in Men on Active Surveillance for Early-stage Prostate Cancer: Implications for Focal Therapy. Eur Urol Oncol. 2022 02; 5(1):61-69. Fasulo V, Cowan JE, Maggi M, Washington SL, Nguyen HG, Shinohara K, Lazzeri M, Casale P, Carroll PR. PMID: 33069628.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    17. Reply by Authors. J Urol. 2020 12; 204(6):1221. Lonergan PE, Washington SL, Cowan JE, Zhao S, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 32969756.
      View in: PubMed   Mentions:    Fields:    
    18. Clinical Utility of 4Kscore®, ExosomeDx™ and Magnetic Resonance Imaging for the Early Detection of High Grade Prostate Cancer. J Urol. 2021 02; 205(2):452-460. de la Calle CM, Fasulo V, Cowan JE, Lonergan PE, Maggi M, Gadzinski AJ, Yeung RA, Saita A, Cooperberg MR, Shinohara K, Carroll PR, Nguyen HG. PMID: 32897802.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    19. How Often Does Magnetic Resonance Imaging Detect Prostate Cancer Missed by Transrectal Ultrasound? Eur Urol Focus. 2021 Nov; 7(6):1268-1273. Herlemann A, Overland MR, Washington SL, Cowan JE, Westphalen AC, Carroll PR, Nguyen HG, Shinohara K, Cooperberg MR. PMID: 32868222.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    20. Multiparametric Magnetic Resonance Imaging Alone is Insufficient to Detect Grade Reclassification in Active Surveillance for Prostate Cancer. Eur Urol. 2020 10; 78(4):515-517. Chu CE, Lonergan PE, Washington SL, Cowan JE, Shinohara K, Westphalen AC, Carroll PR, Cooperberg MR. PMID: 32631744.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    21. Risk Factors for Biopsy Reclassification over Time in Men on Active Surveillance for Early Stage Prostate Cancer. J Urol. 2020 12; 204(6):1216-1221. Lonergan PE, Washington SL, Cowan JE, Zhao S, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 32519915.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    22. MRI-Based Prostate-Specific Antigen Density Predicts Gleason Score Upgrade in an Active Surveillance Cohort. AJR Am J Roentgenol. 2020 03; 214(3):574-578. Washington SL, Baskin AS, Ameli N, Nguyen HG, Westphalen AC, Shinohara K, Carroll PR. PMID: 31913068.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    23. A 17-Gene Genomic Prostate Score as a Predictor of Adverse Pathology in Men on Active Surveillance. J Urol. 2019 10; 202(4):702-709. Kornberg Z, Cooperberg MR, Cowan JE, Chan JM, Shinohara K, Simko JP, Tenggara I, Carroll PR. PMID: 31026214.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    24. Differences in negative predictive value of prostate MRI based in men with suspected or known cancer. Radiol Bras. 2019 Sep-Oct; 52(5):281-286. Baghdanian AA, Kim YJ, Baghdanian AH, Nguyen HN, Shinohara K, Westphalen AC. PMID: 31656343; PMCID: PMC6808619.
      View in: PubMed   Mentions: 3  
    25. Evaluating the Safety of Active Surveillance: Outcomes of Deferred Radical Prostatectomy after an Initial Period of Surveillance. J Urol. 2019 09; 202(3):506-510. Balakrishnan AS, Cowan JE, Cooperberg MR, Shinohara K, Nguyen HG, Carroll PR. PMID: 30958738.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    26. Detection of clinically signifi cant prostate cancer with PIRADS v2 scores, PSA density, and ADC values in regions with and without mpMRI visible lesions. Int Braz J Urol. 2019 Jul-Aug; 45(4):713-723. Westphalen AC, Fazel F, Nguyen H, Cabarrus M, Hanley-Knutson K, Shinohara K, Carroll PR. PMID: 31136112; PMCID: PMC6837611.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    27. The use of prostate MR for targeting prostate biopsies. BJR Open. 2019; 1(1):20180044. Kelley RP, Zagoria RJ, Nguyen HG, Shinohara K, Westphalen AC. PMID: 33178929; PMCID: PMC7592478.
      View in: PubMed   Mentions: 1  
    28. A Mobile Health Intervention for Prostate Biopsy Patients Reduces Appointment Cancellations: Cohort Study. J Med Internet Res. 2019 06 02; 21(6):e14094. Balakrishnan AS, Nguyen HG, Shinohara K, Au Yeung R, Carroll PR, Odisho AY. PMID: 31199294; PMCID: PMC6592401.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    29. Single-fraction brachytherapy as monotherapy for early-stage prostate cancer: The UCSF experience. Brachytherapy. 2019 Jul - Aug; 18(4):470-476. Xu MJ, Chen KS, Chang AJ, Lazar A, Shinohara K, Cunha JAM, Hsu IC. PMID: 30954399.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    30. NMR quantification of lactate production and efflux and glutamate fractional enrichment in living human prostate biopsies cultured with [1,6-13 C2 ]glucose. Magn Reson Med. 2019 08; 82(2):566-576. Bancroft Brown J, Sriram R, VanCriekinge M, Delos Santos R, Sun J, Delos Santos J, Tabatabai ZL, Shinohara K, Nguyen H, Peehl DM, Kurhanewicz J. PMID: 30924180; PMCID: PMC7150535.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    31. Genomic Prostate Score, PI-RADS™ version 2 and Progression in Men with Prostate Cancer on Active Surveillance. J Urol. 2019 02; 201(2):300-307. Kornberg Z, Cowan JE, Westphalen AC, Cooperberg MR, Chan JM, Zhao S, Shinohara K, Carroll PR. PMID: 30179620.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    32. Impact of Staging 68Ga-PSMA-11 PET Scans on Radiation Treatment Plansin Patients With Prostate Cancer. Urology. 2019 03; 125:154-162. Wu SY, Boreta L, Shinohara K, Nguyen H, Gottschalk AR, Hsu IC, Roach M, Westphalen AC, Feng FY, Carroll PR, Chang AJ, Hope TA. PMID: 30580002.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    33. Effects of Initial Gleason Grade on Outcomes during Active Surveillance for Prostate Cancer. Eur Urol Oncol. 2018 10; 1(5):386-394. Masic S, Cowan JE, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 31158077.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    34. Improved rectal dosimetry with the use of SpaceOAR during high-dose-rate brachytherapy. Brachytherapy. 2018 Mar - Apr; 17(2):259-264. Wu SY, Boreta L, Wu A, Cheung JP, Cunha JAM, Shinohara K, Chang AJ. PMID: 29203149.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic Health
    35. Impact of Lesion Visibility on Transrectal Ultrasound on the Prediction of Clinically Significant Prostate Cancer (Gleason Score 3 + 4 or Greater) with Transrectal Ultrasound-Magnetic Resonance Imaging Fusion Biopsy. J Urol. 2018 03; 199(3):699-705. Garcia-Reyes K, Nguyen HG, Zagoria RJ, Shinohara K, Carroll PR, Behr SC, Westphalen AC. PMID: 28941918.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    36. A novel urethral sparing technique for high-dose-rate prostate brachytherapy after transurethral resection of the prostate. Brachytherapy. 2017 Nov - Dec; 16(6):1113-1118. Kunogi H, Cunha JAM, Chang AJ, Gadzinski AJ, Shinohara K, Hsu IC. PMID: 28869143.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    37. Active Surveillance in Younger Men With Prostate Cancer. J Clin Oncol. 2017 Jun 10; 35(17):1898-1904. Leapman MS, Cowan JE, Nguyen HG, Shinohara KK, Perez N, Cooperberg MR, Catalona WJ, Carroll PR. PMID: 28346806; PMCID: PMC5466007.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    38. Magnetic Resonance Imaging-Ultrasound Fusion Biopsy During Prostate Cancer Active Surveillance. Eur Urol. 2017 08; 72(2):275-281. Tran GN, Leapman MS, Nguyen HG, Cowan JE, Shinohara K, Westphalen AC, Carroll PR. PMID: 27595378.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    39. Validity of the Cancer of the Prostate Risk Assessment Score Derived From Targeted Biopsy: Modeling Evidence From Ultrasound Lesion-Directed Biopsy. Clin Genitourin Cancer. 2017 02; 15(1):93-99. Leapman MS, Ameli N, Shinohara K, Nguyen HG, Meng MV, Cooperberg MR, Carroll PR. PMID: 27522449.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    40. Quantified Clinical Risk Change as an End Point During Prostate Cancer Active Surveillance. Eur Urol. 2017 09; 72(3):329-332. Leapman MS, Ameli N, Cooperberg MR, Chu C, Hussein A, Shinohara K, Carroll PR. PMID: 27157998.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    41. Serial Anatomical Prostate Ultrasound during Prostate Cancer Active Surveillance. J Urol. 2016 Sep; 196(3):727-33. Eltemamy MM, Leapman MS, Cowan JE, Westphalen A, Shinohara K, Carroll PR. PMID: 27117443.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    42. Long-term Outcomes Following Radiation Therapy For Prostate Cancer Patients With Lymph Node Metastases at Diagnosis Treated With and Without Surgery. Am J Clin Oncol. 2016 Apr; 39(2):167-72. Crehange G, Izaguirre A, Weinberg V, Hsu CC, Gottschalk AR, Hsu IC, Shinohara K, Carroll P, Roach M. PMID: 24441584.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    43. Sentinel lymph node imaging guided IMRT for prostate cancer: Individualized pelvic radiation therapy versus RTOG guidelines. Adv Radiat Oncol. 2016 Jan-Mar; 1(1):51-58. Chen CP, Johnson J, Seo Y, Weinberg VK, Shinohara K, Hsu IJ, Roach M. PMID: 28799574; PMCID: PMC5506713.
      View in: PubMed   Mentions:
    44. Patient- and treatment-specific predictors of genitourinary function after high-dose-rate monotherapy for favorable prostate cancer. Brachytherapy. 2015 Nov-Dec; 14(6):795-800. Raleigh DR, Chang AJ, Tomlin B, Cunha JA, Braunstein SE, Shinohara K, Gottschalk AR, Roach M, Hsu IC. PMID: 26198421.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    45. Immediate versus delayed radical prostatectomy: updated outcomes following active surveillance of prostate cancer. Eur Urol. 2015 Sep; 68(3):458-63. Filippou P, Welty CJ, Cowan JE, Perez N, Shinohara K, Carroll PR. PMID: 26138041.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    46. Patterns of Local Failure following Radiation Therapy for Prostate Cancer. J Urol. 2015 Oct; 194(4):977-82. Jalloh M, Leapman MS, Cowan JE, Shinohara K, Greene KL, Roach M, Chang AJ, Chan JM, Simko JP, Carroll PR. PMID: 25983194.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    47. Untreated Gleason Grade Progression on Serial Biopsies during Prostate Cancer Active Surveillance: Clinical Course and Pathological Outcomes. J Urol. 2015 Jul; 194(1):85-90. Hussein AA, Welty CJ, Ameli N, Cowan JE, Leapman M, Porten SP, Shinohara K, Carroll PR. PMID: 25623742.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    48. Extended followup and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancer. J Urol. 2015 Mar; 193(3):807-11. Welty CJ, Cowan JE, Nguyen H, Shinohara K, Perez N, Greene KL, Chan JM, Meng MV, Simko JP, Cooperberg MR, Carroll PR. PMID: 25261803.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    49. Pre-plan parameters predict post-implant D90 ≥ 140 Gy for (125)I permanent prostate implants. J Contemp Brachytherapy. 2014 Jun; 6(2):143-53. Alexander J, Weinberg V, Gottschalk AR, Hsu IC, Shinohara K, Roach M. PMID: 25097554; PMCID: PMC4105644.
      View in: PubMed   Mentions: 2  
    50. Management of an increasing prostate-specific antigen level after negative prostate biopsy. Urol Clin North Am. 2014 May; 41(2):327-38. Shinohara K, Nguyen H, Masic S. PMID: 24725493.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    51. Physical activity and prostate gene expression in men with low-risk prostate cancer. Cancer Causes Control. 2014 Apr; 25(4):515-23. Magbanua MJ, Richman EL, Sosa EV, Jones LW, Simko J, Shinohara K, Haqq CM, Carroll PR, Chan JM. PMID: 24504435; PMCID: PMC3990413.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    52. Cold spot mapping inferred from MRI at time of failure predicts biopsy-proven local failure after permanent seed brachytherapy in prostate cancer patients: implications for focal salvage brachytherapy. Radiother Oncol. 2013 Nov; 109(2):246-50. Crehange G, Krishnamurthy D, Cunha JA, Pickett B, Kurhanewicz J, Hsu IC, Gottschalk AR, Shinohara K, Roach M, Pouliot J. PMID: 24231238; PMCID: PMC4081029.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    53. Long-term follow-up of International Prostate Symptom Score (IPSS) in men following prostate brachytherapy. World J Urol. 2014 Aug; 32(4):1061-6. Li X, Fang D, Cooperberg MR, Whitson JM, Lue TF, Zhou L, Shinohara K. PMID: 24141807.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    54. Predictors of pathologic progression on biopsy among men on active surveillance for localized prostate cancer: the value of the pattern of surveillance biopsies. Eur Urol. 2014 Aug; 66(2):337-42. Cary KC, Cowan JE, Sanford M, Shinohara K, Perez N, Chan JM, Meng MV, Carroll PR. PMID: 24035632.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    55. The role of metabolic imaging in radiation therapy of prostate cancer. NMR Biomed. 2014 Jan; 27(1):100-11. Zhang VY, Westphalen A, Delos Santos L, Tabatabai ZL, Shinohara K, Vigneron DB, Kurhanewicz J. PMID: 23940096; PMCID: PMC3864570.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    56. Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes. Int J Radiat Oncol Biol Phys. 2013 Jun 01; 86(2):324-9. Chen CP, Weinberg V, Shinohara K, Roach M, Nash M, Gottschalk A, Chang AJ, Hsu IC. PMID: 23474112.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansPHPublic Health
    57. Local staging of prostate cancer: comparative accuracy of T2-weighted endorectal MR imaging and transrectal ultrasound. Clin Imaging. 2012 Sep-Oct; 36(5):547-52. Jung AJ, Coakley FV, Shinohara K, Carroll PR, Kurhanewicz J, Cowan JE, Westphalen AC. PMID: 22920360; PMCID: PMC3694423.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    58. Feasibility of MR imaging/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer. Int J Radiat Oncol Biol Phys. 2013 Feb 01; 85(2):370-7. Hsu CC, Hsu H, Pickett B, Crehange G, Hsu IC, Dea R, Weinberg V, Gottschalk AR, Kurhanewicz J, Shinohara K, Roach M. PMID: 22672747.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansPHPublic Health
    59. Regional cell proliferation in microdissected human prostate specimens after heavy water labeling in vivo: correlation with prostate epithelial cells isolated from seminal fluid. Clin Cancer Res. 2012 Jun 15; 18(12):3250-60. Hayes GM, Simko J, Holochwost D, Kuchinsky K, Busch R, Misell L, Murphy EJ, Carroll P, Chan J, Shinohara K, Hellerstein MK. PMID: 22553345.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    60. Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. BJU Int. 2012 Feb; 109 Suppl 1:22-9. Grimm P, Billiet I, Bostwick D, Dicker AP, Frank S, Immerzeel J, Keyes M, Kupelian P, Lee WR, Machtens S, Mayadev J, Moran BJ, Merrick G, Millar J, Roach M, Stock R, Shinohara K, Scholz M, Weber E, Zietman A, Zelefsky M, Wong J, Wentworth S, Vera R, Langley S. PMID: 22239226.
      View in: PubMed   Mentions: 152     Fields:    Translation:Humans
    61. Utility of PCA3 in patients undergoing repeat biopsy for prostate cancer. Prostate Cancer Prostatic Dis. 2012 Mar; 15(1):100-5. Wu AK, Reese AC, Cooperberg MR, Sadetsky N, Shinohara K. PMID: 22042252.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    62. Changes in cancer volume in serial biopsies of men on active surveillance for early stage prostate cancer. J Urol. 2011 Nov; 186(5):1825-9. Porten SP, Whitson JM, Cowan JE, Perez N, Shinohara K, Carroll PR. PMID: 21944082.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    63. Gene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementation. PLoS One. 2011; 6(9):e24004. Magbanua MJ, Roy R, Sosa EV, Weinberg V, Federman S, Mattie MD, Hughes-Fulford M, Simko J, Shinohara K, Haqq CM, Carroll PR, Chan JM. PMID: 21912659; PMCID: PMC3164676.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    64. Correlation of phospholipid metabolites with prostate cancer pathologic grade, proliferative status and surgical stage - impact of tissue environment. NMR Biomed. 2011 Jul; 24(6):691-9. Keshari KR, Tsachres H, Iman R, Delos Santos L, Tabatabai ZL, Shinohara K, Vigneron DB, Kurhanewicz J. PMID: 21793074; PMCID: PMC3653775.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    65. Mapping of lymphatic drainage from the prostate using filtered 99mTc-sulfur nanocolloid and SPECT/CT. J Nucl Med. 2011 Jul; 52(7):1068-72. Seo Y, Aparici CM, Chen CP, Hsu C, Kased N, Schreck C, Costouros N, Hawkins R, Shinohara K, Roach Iii M. PMID: 21680690; PMCID: PMC3129454.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCellsCTClinical Trials
    66. [Cryosurgery]. Nihon Rinsho. 2011 Jun; 69 Suppl 5:572-5. Shinohara K. PMID: 22208046.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    67. Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance. J Clin Oncol. 2011 Jul 10; 29(20):2795-800. Porten SP, Whitson JM, Cowan JE, Cooperberg MR, Shinohara K, Perez N, Greene KL, Meng MV, Carroll PR. PMID: 21632511.
      View in: PubMed   Mentions: 75     Fields:    Translation:Humans
    68. Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment. BJU Int. 2011 Apr; 107(8):1232-7. Dall'Era MA, Cowan JE, Simko J, Shinohara K, Davies B, Konety BR, Meng MV, Perez N, Greene K, Carroll PR. PMID: 20804478.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    69. The relationship between prostate specific antigen change and biopsy progression in patients on active surveillance for prostate cancer. J Urol. 2011 May; 185(5):1656-60. Whitson JM, Porten SP, Hilton JF, Cowan JE, Perez N, Cooperberg MR, Greene KL, Meng MV, Simko JP, Shinohara K, Carroll PR. PMID: 21419438.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansPHPublic Health
    70. Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: technique, early toxicity, and PSA response. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):228-34. Jabbari S, Weinberg VK, Kaprealian T, Hsu IC, Ma L, Chuang C, Descovich M, Shiao S, Shinohara K, Roach M, Gottschalk AR. PMID: 21183287.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    71. High-dose-rate brachytherapy boost for prostate cancer: comparison of two different fractionation schemes. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):222-7. Kaprealian T, Weinberg V, Speight JL, Gottschalk AR, Roach M, Shinohara K, Hsu IC. PMID: 21163586.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    72. Outcomes of active surveillance for men with intermediate-risk prostate cancer. J Clin Oncol. 2011 Jan 10; 29(2):228-34. Cooperberg MR, Cowan JE, Hilton JF, Reese AC, Zaid HB, Porten SP, Shinohara K, Meng MV, Greene KL, Carroll PR. PMID: 21115873; PMCID: PMC3058278.
      View in: PubMed   Mentions: 95     Fields:    Translation:Humans
    73. Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer. Cancer Causes Control. 2011 Jan; 22(1):141-50. Chan JM, Weinberg V, Magbanua MJ, Sosa E, Simko J, Shinohara K, Federman S, Mattie M, Hughes-Fulford M, Haqq C, Carroll PR. PMID: 21103921; PMCID: PMC3002170.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    74. Toward adaptive stereotactic robotic brachytherapy for prostate cancer: demonstration of an adaptive workflow incorporating inverse planning and an MR stealth robot. Minim Invasive Ther Allied Technol. 2010 Aug; 19(4):189-202. Cunha JA, Hsu IC, Pouliot J, Roach Iii M, Shinohara K, Kurhanewicz J, Reed G, Stoianovici D. PMID: 20642386; PMCID: PMC3108452.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    75. Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging. Radiology. 2010 Jul; 256(1):176-83. Fradet V, Kurhanewicz J, Cowan JE, Karl A, Coakley FV, Shinohara K, Carroll PR. PMID: 20505068; PMCID: PMC2897693.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansPHPublic Health
    76. Phase II trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: preliminary results of RTOG 0321. Int J Radiat Oncol Biol Phys. 2010 Nov 01; 78(3):751-8. Hsu IC, Bae K, Shinohara K, Pouliot J, Purdy J, Ibbott G, Speight J, Vigneault E, Ivker R, Sandler H. PMID: 20207506; PMCID: PMC2946454.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCTClinical Trials
    77. Equivalent biochemical control and improved prostate-specific antigen nadir after permanent prostate seed implant brachytherapy versus high-dose three-dimensional conformal radiotherapy and high-dose conformal proton beam radiotherapy boost. Int J Radiat Oncol Biol Phys. 2010 Jan 01; 76(1):36-42. Jabbari S, Weinberg VK, Shinohara K, Speight JL, Gottschalk AR, Hsu IC, Pickett B, McLaughlin PW, Sandler HM, Roach M. PMID: 19409729.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    78. Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR-MAS spectroscopy. NMR Biomed. 2010 May; 23(4):391-8. Santos CF, Kurhanewicz J, Tabatabai ZL, Simko JP, Keshari KR, Gbegnon A, Santos RD, Federman S, Shinohara K, Carroll PR, Haqq CM, Swanson MG. PMID: 20033906; PMCID: PMC2891902.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    79. A pretreatment nomogram predicting biochemical failure after salvage cryotherapy for locally recurrent prostate cancer. BJU Int. 2010 Jul; 106(2):194-8. Spiess PE, Katz AE, Chin JL, Bahn D, Cohen JK, Shinohara K, Hernandez M, Bossier J, Kassouf W, Pisters LL. PMID: 19922545.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    80. The adjunctive use of power Doppler imaging in the preoperative assessment of prostate cancer. BJU Int. 2010 May; 105(9):1237-41. Eisenberg ML, Cowan JE, Carroll PR, Shinohara K. PMID: 19888980.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    81. Pain: easing the pain: local anesthesia for prostate biopsy. Nat Rev Urol. 2009 Jul; 6(7):360-1. Shinohara K. PMID: 19578353.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    82. Postoperative nomogram predicting the 9-year probability of prostate cancer recurrence after permanent prostate brachytherapy using radiation dose as a prognostic variable. Int J Radiat Oncol Biol Phys. 2010 Mar 15; 76(4):1061-5. Potters L, Roach M, Davis BJ, Stock RG, Ciezki JP, Zelefsky MJ, Stone NN, Fearn PA, Yu C, Shinohara K, Kattan MW. PMID: 19540064.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    83. Peak flow rate is the best predictor of acute urinary retention following prostate brachytherapy: our experience and literature review. Int J Urol. 2009 Jun; 16(6):558-60. Ikeda T, Shinohara K. PMID: 19456987.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    84. High-dose-rate brachytherapy for localized prostate adenocarcinoma post abdominoperineal resection of the rectum and pelvic irradiation: Technique and experience. Brachytherapy. 2009 Oct-Dec; 8(4):339-44. Jabbari S, Hsu IC, Kawakami J, Weinberg VK, Speight JL, Gottschalk AR, Roach M, Shinohara K. PMID: 19428310.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    85. The importance of tumor palpability and transrectal ultrasonographic appearance in the contemporary clinical staging of prostate cancer. Urol Oncol. 2011 Mar-Apr; 29(2):171-6. Eisenberg ML, Cowan JE, Davies BJ, Carroll PR, Shinohara K. PMID: 19362864.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    86. Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy. BJU Int. 2009 Sep; 104(5):600-4. Aaronson DS, Yamasaki I, Gottschalk A, Speight J, Hsu IC, Pickett B, Roach M, Shinohara K. PMID: 19245439.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    87. Re: Residual urinary volume and urinary tract infection--when are they linked?: J. C. Truzzi, F. M. Almeida, E. C. Nunes and M. V. Sadi, J Urol 2008; 180: 182-185. J Urol. 2009 Feb; 181(2):919; author reply 919-20. Breyer BN, Shinohara K. PMID: 19110278.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    88. Best practice statement on cryosurgery for the treatment of localized prostate cancer. J Urol. 2008 Nov; 180(5):1993-2004. Babaian RJ, Donnelly B, Bahn D, Baust JG, Dineen M, Ellis D, Katz A, Pisters L, Rukstalis D, Shinohara K, Thrasher JB. PMID: 18817934.
      View in: PubMed   Mentions: 76     Fields:    Translation:Humans
    89. Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues. Magn Reson Med. 2008 Sep; 60(3):510-6. Tessem MB, Swanson MG, Keshari KR, Albers MJ, Joun D, Tabatabai ZL, Simko JP, Shinohara K, Nelson SJ, Vigneron DB, Gribbestad IS, Kurhanewicz J. PMID: 18727052; PMCID: PMC2613807.
      View in: PubMed   Mentions: 91     Fields:    Translation:Humans
    90. Partial salvage cryoablation of the prostate for recurrent prostate cancer after radiotherapy failure. Urology. 2008 Dec; 72(6):1315-8. Eisenberg ML, Shinohara K. PMID: 18597824.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    91. Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2009 Feb 01; 73(2):341-6. Stone NN, Potters L, Davis BJ, Ciezki JP, Zelefsky MJ, Roach M, Shinohara K, Fearn PA, Kattan MW, Stock RG. PMID: 18597953.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    92. Quantification of choline- and ethanolamine-containing metabolites in human prostate tissues using 1H HR-MAS total correlation spectroscopy. Magn Reson Med. 2008 Jul; 60(1):33-40. Swanson MG, Keshari KR, Tabatabai ZL, Simko JP, Shinohara K, Carroll PR, Zektzer AS, Kurhanewicz J. PMID: 18581409; PMCID: PMC2643975.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    93. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc Natl Acad Sci U S A. 2008 Jun 17; 105(24):8369-74. Ornish D, Magbanua MJ, Weidner G, Weinberg V, Kemp C, Green C, Mattie MD, Marlin R, Simko J, Shinohara K, Haqq CM, Carroll PR. PMID: 18559852; PMCID: PMC2430265.
      View in: PubMed   Mentions: 93     Fields:    Translation:HumansCells
    94. Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer. 2008 Jun 15; 112(12):2664-70. Dall'Era MA, Konety BR, Cowan JE, Shinohara K, Stauf F, Cooperberg MR, Meng MV, Kane CJ, Perez N, Master VA, Carroll PR. PMID: 18433013.
      View in: PubMed   Mentions: 120     Fields:    Translation:HumansCTClinical Trials
    95. Three-dimensional sonography with needle tracking: role in diagnosis and treatment of prostate cancer. J Ultrasound Med. 2008 Jun; 27(6):895-905. Shen F, Shinohara K, Kumar D, Khemka A, Simoneau AR, Werahera PN, Li L, Guo Y, Narayanan R, Wei L, Barqawi A, Crawford ED, Davatzikos C, Suri JS. PMID: 18499849; PMCID: PMC3402711.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    96. Ejaculatory duct manometry in normal men and in patients with ejaculatory duct obstruction. J Urol. 2008 Jul; 180(1):255-60; discussion 260. Eisenberg ML, Walsh TJ, Garcia MM, Shinohara K, Turek PJ. PMID: 18499178.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    97. Prostate cancer: is inapparent tumor at endorectal MR and MR spectroscopic imaging a favorable prognostic finding in patients who select active surveillance? Radiology. 2008 May; 247(2):444-50. Cabrera AR, Coakley FV, Westphalen AC, Lu Y, Zhao S, Shinohara K, Carroll PR, Kurhanewicz J. PMID: 18430877; PMCID: PMC3705558.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    98. Technique for implantation of fiducial markers in the prostate. Urology. 2008 Feb; 71(2):196-200. Shinohara K, Roach M. PMID: 18308082.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    99. Comparison of prostate and transition zone volume measured by the ellipsoid and planimetric methods with transrectal ultrasonography before seed implantation of prostate cancer. Int J Urol. 2008 Feb; 15(2):190-1. Ikeda T, Shinohara K. PMID: 18269465.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    100. Cryotherapy. Int J Clin Oncol. 2007 Dec; 12(6):416-26. Shinohara K. PMID: 18071860.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    101. Positional stability of electromagnetic transponders used for prostate localization and continuous, real-time tracking. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):1199-206. Litzenberg DW, Willoughby TR, Balter JM, Sandler HM, Wei J, Kupelian PA, Cunningham AA, Bock A, Aubin M, Roach M, Shinohara K, Pouliot J. PMID: 17513060.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    102. Daily electronic portal imaging of implanted gold seed fiducials in patients undergoing radiotherapy after radical prostatectomy. Int J Radiat Oncol Biol Phys. 2007 Feb 01; 67(2):610-9. Schiffner DC, Gottschalk AR, Lometti M, Aubin M, Pouliot J, Speight J, Hsu IC, Shinohara K, Roach M. PMID: 17236978.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    103. Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys. 2007 Mar 15; 67(4):1106-12. Lee B, Shinohara K, Weinberg V, Gottschalk AR, Pouliot J, Roach M, Hsu IC. PMID: 17197119.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    104. Improving cancer detection by prostate biopsy: the role of core number and site. Nat Clin Pract Urol. 2006 Oct; 3(10):526-7. Shinohara K. PMID: 17031375.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    105. Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy. Magn Reson Med. 2006 Jun; 55(6):1257-64. Swanson MG, Zektzer AS, Tabatabai ZL, Simko J, Jarso S, Keshari KR, Schmitt L, Carroll PR, Shinohara K, Vigneron DB, Kurhanewicz J. PMID: 16685733.
      View in: PubMed   Mentions: 94     Fields:    Translation:HumansCells
    106. Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer. Int J Radiat Oncol Biol Phys. 2006 Jun 01; 65(2):528-34. Willoughby TR, Kupelian PA, Pouliot J, Shinohara K, Aubin M, Roach M, Skrumeda LL, Balter JM, Litzenberg DW, Hadley SW, Wei JT, Sandler HM. PMID: 16690435.
      View in: PubMed   Mentions: 114     Fields:    Translation:Humans
    107. Three-dimensional conformal external beam radiotherapy compared with permanent prostate implantation in low-risk prostate cancer based on endorectal magnetic resonance spectroscopy imaging and prostate-specific antigen level. Int J Radiat Oncol Biol Phys. 2006 May 01; 65(1):65-72. Pickett B, Kurhanewicz J, Pouliot J, Weinberg V, Shinohara K, Coakley F, Roach M. PMID: 16517094.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    108. Saw palmetto for benign prostatic hyperplasia. N Engl J Med. 2006 Feb 09; 354(6):557-66. Bent S, Kane C, Shinohara K, Neuhaus J, Hudes ES, Goldberg H, Avins AL. PMID: 16467543.
      View in: PubMed   Mentions: 93     Fields:    Translation:HumansAnimalsCTClinical Trials
    109. Local anesthesia during 10 core biopsy of the prostate: comparison of 2 methods. J Urol. 2005 Mar; 173(3):742-5. Mutaguchi K, Shinohara K, Matsubara A, Yasumoto H, Mita K, Usui T. PMID: 15711260.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    110. Combined modality treatment with high-dose-rate brachytherapy boost for locally advanced prostate cancer. Brachytherapy. 2005; 4(3):202-6. Hsu IC, Cabrera AR, Weinberg V, Speight J, Gottschalk AR, Roach M, Shinohara K. PMID: 16182220.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    111. Ferromagnetic thermal ablation of locally recurrent prostate cancer: prostate specific antigen results and immediate/intermediate morbidities. J Urol. 2004 Dec; 172(6 Pt 1):2197-202. Master VA, Shinohara K, Carroll PR. PMID: 15538231.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    112. Use of MRI and spectroscopy in evaluation of external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2004 Nov 15; 60(4):1047-55. Pickett B, Kurhanewicz J, Coakley F, Shinohara K, Fein B, Roach M. PMID: 15519774.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    113. Thermal ablation of prostate diseases: advantages and limitations. Int J Hyperthermia. 2004 Nov; 20(7):679-97. Shinohara K. PMID: 15675665.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    114. Prostate movement during simulation resulting from retrograde urethrogram compared with "natural" prostate movement. Int J Radiat Oncol Biol Phys. 2004 Oct 01; 60(2):470-5. Liu YM, Ling S, Langen KM, Shinohara K, Weinberg V, Pouliot J, Roach M. PMID: 15380581.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    115. Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience. Radiology. 2004 Nov; 233(2):441-8. Coakley FV, Teh HS, Qayyum A, Swanson MG, Lu Y, Roach M, Pickett B, Shinohara K, Vigneron DB, Kurhanewicz J. PMID: 15375223.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    116. Time to metabolic atrophy after permanent prostate seed implantation based on magnetic resonance spectroscopic imaging. Int J Radiat Oncol Biol Phys. 2004 Jul 01; 59(3):665-73. Pickett B, Ten Haken RK, Kurhanewicz J, Qayyum A, Shinohara K, Fein B, Roach M. PMID: 15183469.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    117. Daily electronic portal imaging for morbidly obese men undergoing radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2004 May 01; 59(1):6-10. Millender LE, Aubin M, Pouliot J, Shinohara K, Roach M. PMID: 15093893.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    118. A prospective comparison of 3 diagnostic methods to evaluate ejaculatory duct obstruction. J Urol. 2004 Jan; 171(1):232-5; discussion 235-6. Purohit RS, Wu DS, Shinohara K, Turek PJ. PMID: 14665883.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    119. Prostate cancer: cryotherapy. Urol Clin North Am. 2003 Nov; 30(4):725-36, viii. Shinohara K. PMID: 14680310.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    120. Evaluation of ultrasound-based prostate localization for image-guided radiotherapy. Int J Radiat Oncol Biol Phys. 2003 Nov 01; 57(3):635-44. Langen KM, Pouliot J, Anezinos C, Aubin M, Gottschalk AR, Hsu IC, Lowther D, Liu YM, Shinohara K, Verhey LJ, Weinberg V, Roach M. PMID: 14529767.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    121. Choosing imaging modality in 2003. J Urol. 2003 Sep; 170(3):803. Shinohara K. PMID: 12913702.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    122. The utility of apical anterior horn biopsies in prostate cancer detection. Urol Oncol. 2003 Sep-Oct; 21(5):361-5. Meng MV, Franks JH, Presti JC, Shinohara K. PMID: 14670545.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    123. (Non)-migration of radiopaque markers used for on-line localization of the prostate with an electronic portal imaging device. Int J Radiat Oncol Biol Phys. 2003 Jul 01; 56(3):862-6. Pouliot J, Aubin M, Langen KM, Liu YM, Pickett B, Shinohara K, Roach M. PMID: 12788196.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    124. Imaging clinically localized prostate cancer. Urol Clin North Am. 2003 May; 30(2):279-93. Purohit RS, Shinohara K, Meng MV, Carroll PR. PMID: 12735504.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    125. Significance of high-grade prostatic intraepithelial neoplasia on prostate biopsy. Urol Oncol. 2003 Mar-Apr; 21(2):145-51. Meng MV, Shinohara K, Grossfeld GD. PMID: 12856644.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    126. Transperineal prostate biopsy after abdominoperineal resection. J Urol. 2003 Jan; 169(1):141-4. Shinohara K, Gulati M, Koppie T, Terris MK. PMID: 12478122.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    127. Rectal wall recurrence of prostatic adenocarcinoma. J Urol. 2002 Nov; 168(5):2120. Koppie TM, Grady BP, Shinohara K. PMID: 12394725.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    128. Sextant prostate biopsies predict side and sextant site of extracapsular extension of prostate cancer. J Urol. 2002 Jul; 168(1):105-9. Elliott SP, Shinohara K, Logan SL, Carroll PR. PMID: 12050501.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    129. Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy. J Urol. 2001 May; 165(5):1409-14. Park S, Shinohara K, Grossfeld GD, Carroll PR. PMID: 11342887.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    130. Prostate volume change after radioactive seed implantation: possible benefit of improved dose volume histogram with perioperative steroid. Int J Radiat Oncol Biol Phys. 2000 Dec 01; 48(5):1461-7. Speight JL, Shinohara K, Pickett B, Weinberg VK, Hsu IC, Roach M. PMID: 11121649.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    131. Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer. J Clin Oncol. 2000 Nov 01; 18(21):3595-603. Small EJ, Frohlich MW, Bok R, Shinohara K, Grossfeld G, Rozenblat Z, Kelly WK, Corry M, Reese DM. PMID: 11054432.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    132. Additional treatments and reimbursement rates associated with prostate cancer treatment for patients undergoing radical prostatectomy, interstitial brachytherapy, and external beam radiotherapy. Urology. 2000 Oct 01; 56(4):622-6. Goharderakhshan RZ, Grossfeld GD, Kassis A, Shinohara K, Roach M, Carroll PR. PMID: 11018618.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    133. [Cryosurgery]. Nihon Rinsho. 2000 Jul; 58 Suppl:306-8. Shinohara K. PMID: 11022736.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    134. Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: potential for dose escalation. Int J Radiat Oncol Biol Phys. 2000 Mar 01; 46(4):851-8. Hsu IC, Pickett B, Shinohara K, Krieg R, Roach M, Phillips T. PMID: 10705005.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    135. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol. 2000 Jan; 163(1):163-6; discussion 166-7. Presti JC, Chang JJ, Bhargava V, Shinohara K. PMID: 10604337.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCTClinical Trials
    136. Number of positive systematic sextant biopsies predicts surgical margin status at radical prostatectomy. Urology. 1999 Oct; 54(4):689-93. Tigrani VS, Bhargava V, Shinohara K, Presti JC. PMID: 10510929.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    137. The efficacy of cryosurgical ablation of prostate cancer: the University of California, San Francisco experience. J Urol. 1999 Aug; 162(2):427-32. Koppie TM, Shinohara K, Grossfeld GD, Presti JC, Carroll PR. PMID: 10411051.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    138. Positive fraction of systematic biopsies predicts risk of relapse after radical prostatectomy. Urology. 1998 Dec; 52(6):1079-84. Presti JC, Shinohara K, Bacchetti P, Tigrani V, Bhargava V. PMID: 9836558.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    139. Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection. J Urol. 1998 Dec; 160(6 Pt 1):2111-4. Chang JJ, Shinohara K, Bhargava V, Presti JC. PMID: 9817334.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    140. Radiation therapy for the management of biopsy proved local recurrence after radical prostatectomy. J Urol. 1998 Nov; 160(5):1748-53. Rogers R, Grossfeld GD, Roach M, Shinohara K, Presti JC, Carroll PR. PMID: 9783945.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    141. Prospective evaluation of systematic sextant transition zone biopsies in large prostates for cancer detection. Urology. 1998 Jul; 52(1):89-93. Chang JJ, Shinohara K, Hovey RM, Montgomery C, Presti JC. PMID: 9671876.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    142. Cryosurgical ablation of prostate cancer: patterns of cancer recurrence. J Urol. 1997 Dec; 158(6):2206-9; discussion 2209-10. Shinohara K, Rhee B, Presti JC, Carroll PR. PMID: 9366345.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    143. The effect of cryosurgical ablation of the prostate on erectile function. Br J Urol. 1997 Dec; 80(6):918-22. Aboseif S, Shinohara K, Borirakchanyavat S, Deirmenjian J, Carroll PR. PMID: 9439410.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    144. Cryosurgery for locally advanced (T3) prostate cancer. Semin Urol Oncol. 1997 Nov; 15(4):244-9. Connolly JA, Shinohara K, Carroll PR. PMID: 9421452.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    145. Systematic sextant biopsies in the prediction of extracapsular extension at radical prostatectomy. Urology. 1997 Sep; 50(3):373-8. Borirakchanyavat S, Bhargava V, Shinohara K, Toke A, Carroll PR, Presti JC. PMID: 9301700.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    146. Accelerated tumor proliferation rates in locally recurrent prostate cancer after radical prostatectomy. J Urol. 1997 Aug; 158(2):515-8. Connolly JA, Presti JC, Cher ML, Chew K, Shinohara K, Carroll PR. PMID: 9224336.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    147. Prostate-specific antigen after cryosurgical ablation of the prostate. Defining the appropriate response. Urol Clin North Am. 1997 May; 24(2):415-20. Connolly JA, Shinohara K, Presti JC, Carroll PR. PMID: 9126239.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    148. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of carcinoma of the prostate: ethnic variations. J Urol. 1997 Mar; 157(3):907-11; discussion 911-2. Presti JC, Hovey R, Bhargava V, Carroll PR, Shinohara K. PMID: 9072597.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    149. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of nonpalpable and stage T1C carcinoma of the prostate. J Urol. 1996 Nov; 156(5):1685-90. Presti JC, Hovey R, Carroll PR, Shinohara K. PMID: 8863571.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    150. Should cryosurgery be considered a therapeutic option in localized prostate cancer? Urol Clin North Am. 1996 Nov; 23(4):623-31. Connolly JA, Shinohara K, Presti JC, Carroll PR. PMID: 8948416.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    151. Prediction of focal extracapsular extension at radical prostatectomy: Relative merit of transrectal ultrasound, endorectal magnetic resonance imaging, prostate specific antigen, prostate specific antigen density, and systematic biopsy. Urol Oncol. 1996 Nov-Dec; 2(6):177-83. Presti JC, Hricak H, Shinohara K, Carroll PR. PMID: 21224166.
      View in: PubMed   Mentions: 1     Fields:    
    152. Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy. Urology. 1996 Oct; 48(4):594-9. Parivar F, Hricak H, Shinohara K, Kurhanewicz J, Vigneron DB, Nelson SJ, Carroll PR. PMID: 8886066.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCTClinical Trials
    153. Comparison of systematic sextant and lesion directed biopsies in prostate cancer detection. Urol Oncol. 1996 Sep-Oct; 2(5):136-8. Seltzer MA, Shinohara K, Bhargava V, Carroll PR, Presti JC. PMID: 21224157.
      View in: PubMed   Mentions: 1     Fields:    
    154. Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging. Radiology. 1996 Aug; 200(2):489-96. Kurhanewicz J, Vigneron DB, Hricak H, Parivar F, Nelson SJ, Shinohara K, Carroll PR. PMID: 8685346.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    155. Cryosurgical treatment of localized prostate cancer (stages T1 to T4): preliminary results. J Urol. 1996 Jul; 156(1):115-20; discussion 120-1. Shinohara K, Connolly JA, Presti JC, Carroll PR. PMID: 8648771.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    156. Comparison of transrectal ultrasound prostatic volume estimation with magnetic resonance imaging volume estimation and surgical specimen weight in patients with benign prostatic hyperplasia. J Clin Ultrasound. 1996 May; 24(4):169-74. Tewari A, Indudhara R, Shinohara K, Schalow E, Woods M, Lee R, Anderson C, Narayan P. PMID: 8727414.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    157. Prostate carcinoma: MR imaging findings after cryosurgery. Radiology. 1996 Mar; 198(3):807-11. Kalbhen CL, Hricak H, Shinohara K, Chen M, Parivar F, Kurhanewicz J, Vigneron DB, Carroll PR. PMID: 8628875.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    158. Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins. Urology. 1996 Feb; 47(2):225-31. Connolly JA, Shinohara K, Presti JC, Carroll PR. PMID: 8607239.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    159. Transrectal ultrasound guided prostatic nerve blockade eases systematic needle biopsy of the prostate. J Urol. 1996 Feb; 155(2):607-9. Nash PA, Bruce JE, Indudhara R, Shinohara K. PMID: 8558671.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCTClinical Trials
    160. Local staging of prostatic carcinoma: comparison of transrectal sonography and endorectal MR imaging. AJR Am J Roentgenol. 1996 Jan; 166(1):103-8. Presti JC, Hricak H, Narayan PA, Shinohara K, White S, Carroll PR. PMID: 8571856.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    161. The significance of prostatic intra-epithelial neoplasia. Br J Urol. 1995 Sep; 76(3):355-9. Aboseif S, Shinohara K, Weidner N, Narayan P, Carroll PR. PMID: 7551846.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    162. High failure rate associated with long-term follow-up of neoadjuvant androgen deprivation followed by radical prostatectomy for stage C prostatic cancer. Br J Urol. 1995 Jun; 75(6):771-7. Cher ML, Shinohara K, Breslin S, Vapnek J, Carroll PR. PMID: 7542137.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    163. Comparison of prostate specific antigen with prostate specific antigen density for 3 clinical applications. J Urol. 1994 Jul; 152(1):120-3. Shinohara K, Wolf JS, Narayan P, Carroll PR. PMID: 7515447.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    164. Transurethral evaporation of prostate (TUEP) with Nd:YAG laser using a contact free beam technique: results in 61 patients with benign prostatic hyperplasia. Urology. 1994 Jun; 43(6):813-20. Narayan P, Fournier G, Indudhara R, Leidich R, Shinohara K, Ingerman A. PMID: 7515205.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    165. Role of penile vascular injury in erectile dysfunction after radical prostatectomy. Br J Urol. 1994 Jan; 73(1):75-82. Aboseif S, Shinohara K, Breza J, Benard F, Narayan P. PMID: 8298902.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    166. Staging accuracy of magnetic resonance imaging versus transrectal ultrasound in stages A and B prostatic cancer. Urol Int. 1994; 53(4):191-5. Vapnek JM, Hricak H, Shinohara K, Popovich M, Carroll P. PMID: 7855937.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    167. Selection of patients for laparoscopic pelvic lymphadenectomy prior to radical prostatectomy: a decision analysis. Urology. 1993 Dec; 42(6):680-8. Wolf JS, Shinohara K, Kerlikowske KM, Narayan P, Stoller ML, Carroll PR. PMID: 8256401.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    168. Combined role of transrectal ultrasonography, Gleason score, and prostate-specific antigen in predicting organ-confined prostate cancer. Urology. 1993 Aug; 42(2):131-7. Wolf JS, Shinohara K, Carroll PR, Narayan P. PMID: 7690168.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    169. The value of prostate specific antigen and transrectal ultrasound guided biopsy in detecting prostatic fossa recurrences following radical prostatectomy. J Urol. 1993 May; 149(5):1024-8. Foster LS, Jajodia P, Fournier G, Shinohara K, Carroll P, Narayan P. PMID: 7683341.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    170. Staging of prostate cancer. Accuracy of transrectal ultrasound enhanced by prostate-specific antigen. Br J Urol. 1992 Nov; 70(5):534-41. Wolf JS, Shinohara K, Narayan P. PMID: 1281724.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    Katsuto's Networks
    Concepts (319)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (65)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.